BRAF V600E mutation is most prominent in melanoma (40–60%), papillary thyroid carcinoma (45%), low grade serous ovarian carcinoma (35%), and in colorectal adenocarcinoma (5–15%) (4). The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.